DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

DRG Oncology Pulse

Stay on top of updates and innovations in the oncology landscape and how it impacts your decisions

Opdivo + Yervoy’s FDA Win for Colorectal Cancer – What Pharma Needs to Know

View more

PARP Inhibitor Cheat Sheet for Oncology Strategists

View more

Oncology: The Big Picture and Key Dynamics Shaping the Market

View more
Ask us your question

Clinical Development Strategies for Checkpoint Inhibitors

View more
Ask us your question

The Biosimilars Games: Who is Doing What and How in the Biosimilars Battlefield?

View more

Treatment Sequencing: Navigating the Complex System of Oncology Pathways

View more

How are NSCLC Treatments Sequenced and What Factors Drive Prescribing?

View more

Oncology Clinical Trial Monitor

View more

What is the U.S. Medical Community's Perception About CAR T-cell Therapies?

View more